Physiological diagnostic criteria for vascular failure

Atsushi Tanaka; Hirofumi Tomiyama; Tatsuya Maruhashi; Yasushi Matsuzawa; Toru Miyoshi; Tomoyuki Kabutoya; Kazuomi Kario; Seigo Sugiyama; Masanori Munakata; Hiroshi Ito; Shinichiro Ueda; Charalambos Vlachopoulos; Yukihito Higashi; Teruo Inoue; Koichi Node

doi:10.1161/HYPERTENSIONAHA.118.11554

Physiological diagnostic criteria for vascular failure

Atsushi Tanaka, Hirofumi Tomiyama, Tatsuya Maruhashi, Yasushi Matsuzawa, Toru Miyoshi, Tomoyuki Kabutoya, Kazuomi Kario, Seigo Sugiyama, Masanori Munakata, Hiroshi Ito, Shinichiro Ueda, Charalambos Vlachopoulos, Yukihito Higashi, Teruo Inoue, Koichi Node

Research output: Contribution to journal › Review article › peer-review

143 Citations (Scopus)

Original language	English
Pages (from-to)	1060-1071
Number of pages	12
Journal	Hypertension
Volume	72
Issue number	5
DOIs	https://doi.org/10.1161/HYPERTENSIONAHA.118.11554
Publication status	Published - 2018

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1161/HYPERTENSIONAHA.118.11554

Cite this

@article{4a27dfa9ecb24350966747227dbb3a51,

title = "Physiological diagnostic criteria for vascular failure",

author = "Atsushi Tanaka and Hirofumi Tomiyama and Tatsuya Maruhashi and Yasushi Matsuzawa and Toru Miyoshi and Tomoyuki Kabutoya and Kazuomi Kario and Seigo Sugiyama and Masanori Munakata and Hiroshi Ito and Shinichiro Ueda and Charalambos Vlachopoulos and Yukihito Higashi and Teruo Inoue and Koichi Node",

note = "Funding Information: K. Kario received research funding from Fukuda Denshi. H. Ito received donation from Fukuda Denshi. Y. Higashi received consulting fees from Mitsubishi Tanabe Pharma Corporation related to this study, as well as honoraria and grants from Teijin, Boehringer Ingelheim, Merck, Sanofi, AstraZeneca, Kyowa Hakko Kirin, Takeda, Astellas, Daiichi Sankyo, Mochida, Nihon Kohden, Shionogi, Nippon Sigmax, Sanwa Kagaku Kenkyusho, Unex, and Kao, and honoraria from Radiometer, Omron, Sumitomo Dainippon, Otsuka, Torii, Kowa, Fujiyakuhin, Amgen Astellas, Nippon Shinyaku, Itamar Medical, Bayer, Eli Lilly, and Ono. The other authors report no conflicts.",

year = "2018",

doi = "10.1161/HYPERTENSIONAHA.118.11554",

language = "English",

volume = "72",

pages = "1060--1071",

journal = "Hypertension",

issn = "0194-911X",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Physiological diagnostic criteria for vascular failure

AU - Tanaka, Atsushi

AU - Tomiyama, Hirofumi

AU - Maruhashi, Tatsuya

AU - Matsuzawa, Yasushi

AU - Miyoshi, Toru

AU - Kabutoya, Tomoyuki

AU - Kario, Kazuomi

AU - Sugiyama, Seigo

AU - Munakata, Masanori

AU - Ito, Hiroshi

AU - Ueda, Shinichiro

AU - Vlachopoulos, Charalambos

AU - Higashi, Yukihito

AU - Inoue, Teruo

AU - Node, Koichi

N1 - Funding Information: K. Kario received research funding from Fukuda Denshi. H. Ito received donation from Fukuda Denshi. Y. Higashi received consulting fees from Mitsubishi Tanabe Pharma Corporation related to this study, as well as honoraria and grants from Teijin, Boehringer Ingelheim, Merck, Sanofi, AstraZeneca, Kyowa Hakko Kirin, Takeda, Astellas, Daiichi Sankyo, Mochida, Nihon Kohden, Shionogi, Nippon Sigmax, Sanwa Kagaku Kenkyusho, Unex, and Kao, and honoraria from Radiometer, Omron, Sumitomo Dainippon, Otsuka, Torii, Kowa, Fujiyakuhin, Amgen Astellas, Nippon Shinyaku, Itamar Medical, Bayer, Eli Lilly, and Ono. The other authors report no conflicts.

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?scp=85055604014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055604014&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.118.11554

DO - 10.1161/HYPERTENSIONAHA.118.11554

M3 - Review article

C2 - 30354826

AN - SCOPUS:85055604014

SN - 0194-911X

VL - 72

SP - 1060

EP - 1071

JO - Hypertension

JF - Hypertension

IS - 5

ER -

Physiological diagnostic criteria for vascular failure

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this